Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
AUTOR(ES)
Saiz, J C
RESUMO
Five neutralizing monoclonal antibodies (nMAbs) obtained against type A5 Spain-86 foot-and-mouth disease virus were used to generate a series of neutralization-resistant variants. In vitro and in vivo assays showed that the variants were fully refractory to neutralization by the selecting nMAb. On the basis of cross-neutralization and binding assays, two neutralizing antigenic sites have been located on the virus surface; one, located near the C-terminus of VP1, displayed a linear epitope, and the second, located on VP2, displayed two conformational epitopes. Nucleotide sequencing of RNA of the parental and variant capsid protein-coding region P1 has placed the amino acid changes at position 198 of VP1 for the first site and at positions 72 and 79 of VP2 for the related epitopes in the second site. The relative importance of these two sites in the biological properties of foot-and-mouth disease virus is discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=240607Documentos Relacionados
- Antigenic sites on foot-and-mouth disease virus type A10.
- Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.
- Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.
- Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.
- Protective Immune Response to Foot-and-Mouth Disease Virus with VP1 Expressed in Transgenic Plants
